Menopause triggers metabolic changes in brain that may promote Alzheimer's

October 10, 2017
Menopause triggers metabolic changes in brain that may promote Alzheimer's
The scan to the left shows brain activity (e.g., metabolism) in a premenopausal woman; the scan to the right shows brain activity in a postmenopausal woman. The color scale reflects brain activity, with brighter colors indicating more activity, and darker colors indicating lower activity. The scan to the right (menopause) looks 'greener' and overall darker, which means that the woman's brain has substantially lower brain activity (more than 30 percent less) than the one to the left (no signs of menopause). Credit: WCM

Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer's disease, a team from Weill Cornell Medicine and the University of Arizona Health Sciences has shown in new research.

The findings, published today in PLoS One, could help solve a longstanding mystery about Alzheimer's, namely, why women get this fatal neurodegenerative disorder more often than men—even accounting for the fact that women on average live longer. The investigators say the results also eventually may lead to the development of screening tests and early interventions to reverse or slow the observed .

Alzheimer's afflicts more than 5 million Americans, including one-third of Americans older than 85, and the disease process is known to begin several decades before dementia sets in.

"This study suggests there may be a critical window of opportunity, when women are in their 40s and 50s, to detect metabolic signs of higher Alzheimer's risk and apply strategies to reduce that risk," said lead author Dr. Lisa Mosconi, who was recruited to Weill Cornell Medicine as an associate professor of neuroscience in neurology.

For the study, Dr. Mosconi and her colleagues, including senior author Dr. Roberta Brinton from the University of Arizona Health Sciences in Tucson, used the imaging test positron emission tomography (PET) to measure the use of glucose—a principal fuel source for cellular activity—in the brains of 43 healthy women ages 40 to 60. Of those, 15 were pre-menopausal, 14 were transitioning to (peri-menopause) and 14 were menopausal.

The tests revealed the women who had undergone menopause or were peri-menopausal had markedly lower levels of glucose metabolism in several key brain regions than those who were pre-menopausal. Scientists in prior studies have seen a similar pattern of "hypometabolism" in the brains of patients in the earliest stages of Alzheimer's—and even in mice that model the disease.

In addition, menopausal and peri-menopausal patients showed lower levels of activity for an important metabolic enzyme called mitochondrial cytochrome oxidase, as well as lower scores on standard memory tests. The strong contrast with pre-menopausal patients remained even when accounting that the menopausal and peri-menopausal women were older.

"Our findings show that the loss of estrogen in menopause doesn't just diminish fertility," said Dr. Mosconi, associate director of the Alzheimer's Prevention Clinic at Weill Cornell Medicine and NewYork-Presbyterian. "It also means the loss of a key neuroprotective element in the female brain and a higher vulnerability to brain aging and Alzheimer's disease. We urgently need to address these problems because, currently, 850 million women worldwide are entering or have entered menopause. Our studies demonstrate that women need medical attention in their 40s, well in advance of any endocrine or neurological symptoms."

The findings add to mounting evidence that there is physiological connection between menopause and Alzheimer's. Dr. Mosconi and colleagues published a study in Neurology in September that linked menopause to increased accumulation of the Alzheimer's-associated protein amyloid beta in the brain. The investigators also observed reduced volumes of gray matter (brain cells) and white matter (nerve fiber bundles) in brain regions that are strongly affected in Alzheimer's.

Menopause long has been known to cause brain-related symptoms, including depression, anxiety, insomnia and cognitive deficits. Scientists widely believe they are caused largely by declines in . Estrogen receptors are found on cells throughout the brain and evidence suggests that reduced signaling through these receptors due to can leave brain cells generally more vulnerable to disease and dysfunction.

More specifically, the authors suggest that the menopausal fall in estrogen may trigger a shift to a "starvation reaction" in brain cells—a metabolic state that is beneficial in the short term but can be harmful in the long term.

"Our work indicates that women may need antioxidants to protect their brain activity and mitochondria in combination with strategies to maintain estrogen levels," Dr. Mosconi said, noting that exercise and foods that are rich in antioxidants, such as flaxseeds, also may help boost estrogen production. "We believe that more research is needed to test efficacy and safety of hormonal-replacement therapies at the very early stages of menopause, and to correlate hormonal changes with risk of Alzheimer's. This is a major priority at our Alzheimer's Prevention Clinic."

Dr. Mosconi and her colleagues now plan to expand their patient group, and also hope to perform longer-term, more comprehensive analyses of neural and metabolic markers during and after menopause. This work may lead to the development of biomarkers that could help investigators identify at-risk patients.

"We really need to follow larger groups of over long periods to see how this menopausal change in metabolism relates to Alzheimer's," she said.

Said Dr. Brinton, a leading neuroscientist in the field of Alzheimer's, the aging female brain and regenerative therapeutics: "Outcomes of this study will provide critical evidence for early changes in the aging female that are relevant to the two-fold greater lifetime risk in Alzheimer's disease. Importantly, these results indicate that we know when to intervene in the aging process to divert the potential for developing this devastating disease."

Explore further: Menopause and estrogen affect muscle function

More information: Lisa Mosconi et al. Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery, PLOS ONE (2017). DOI: 10.1371/journal.pone.0185926

Related Stories

Menopause and estrogen affect muscle function

October 3, 2017
According to a study conducted at the University of Jyväskylä, estrogen acts as a regulator of muscle energy metabolism and muscle cell viability. Menopause leads to the cessation of ovarian estrogen production concurrent ...

Estrogen patch in newly postmenopausal women may reduce Alzheimer's risk

July 12, 2016
Can estrogen preserve brain function and decrease the risk of Alzheimer's disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky ...

Estrogen in the brain prevents obesity and glucose intolerance during menopause in lab animal study

July 18, 2017
Researchers at the University of Cincinnati (UC) have found that adding estrogen in the brain may improve health in obese females after menopause.

Postmenopausal hormone therapy exceeding ten years may protect from dementia

February 16, 2017
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.

Men, women and risk of developing Alzheimer disease: Is there a difference?

August 28, 2017
Are female carriers of the apolipoprotein E ?4 allele, the main genetic risk factor for late-onset Alzheimer disease, at greater risk of developing the disease than men? A new article published by JAMA Neurology examines ...

New recommendations for managing menopausal symptoms in breast cancer survivors

August 22, 2017
A large proportion of the world's estimated 9.3 million breast cancer survivors experience menopausal symptoms or clinical manifestations of estrogen deficiency. A comprehensive review published in the Endocrine Society's ...

Recommended for you

Canola oil linked to worsened memory and learning ability in Alzheimer's

December 7, 2017
Canola oil is one of the most widely consumed vegetable oils in the world, yet surprisingly little is known about its effects on health. Now, a new study published online December 7 in the journal Scientific Reports by researchers ...

Genetics study suggests that education reduces risk of Alzheimer's disease

December 7, 2017
The theory that education protects against Alzheimer's disease has been given further weight by new research from the University of Cambridge, funded by the European Union. The study is published today in the BMJ.

Healthy mitochondria could stop Alzheimer's

December 6, 2017
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called ...

Alzheimer's damage in mice reduced with compound that targets APOE gene

December 6, 2017
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

Lithium in water associated with slower rate of Alzheimer's disease deaths

December 5, 2017
Rates of diabetes and obesity, which are important risk factors for Alzheimer's disease, also decrease if there is a particular amount of lithium in the water, says the study, published recently in the Journal of Alzheimer's ...

Hyperbaric oxygen therapy may alleviate symptoms of Alzheimer's Disease

December 5, 2017
A new Tel Aviv University study reveals that hyperbaric oxygen treatments may ameliorate symptoms experienced by patients with Alzheimer's disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.